FDA enforcement is increasing

Your social media posts are FDA violations waiting to happen.

Every time your medtech company posts on LinkedIn, X, or Instagram without a compliance review, you're risking warning letters, product seizures, and consent decrees. IronPost Media makes every post audit-ready before it goes live.

Built by John Duquette — 20+ years leading sales, marketing, and regulatory operations inside medical device companies including Boston Medical Products, Hayek Medical, and Vapotherm.

4,800+
FDA warning letters issued
to device companies since 2019
$15.6M
Average cost of an FDA
consent decree to resolve
0
Social media posts most
medtech companies review for compliance

Social media is the fastest way for a medical device company to violate FDA regulations.

Fair Balance violations

Posting a device benefit without proportional risk disclosure violates 21 CFR 801 and the FD&C Act. A single LinkedIn post claiming "improved outcomes" without ISI linking is a citable offense.

🛑

Off-label promotion

A hashtag, a reply to a comment, a repost of a clinician's testimonial — any of these can constitute off-label promotion if the content implies use beyond your cleared indications. The FDA doesn't distinguish between intent and impact.

🗃

No audit trail

When the FDA requests your promotional material archive, "we posted it on Instagram" isn't a compliance response. Every piece of social content needs timestamped archival, approval chain documentation, and version history.

📱

Platform-specific traps

Character limits on X force compressed disclosures. Instagram's visual format obscures required safety information. LinkedIn's reshare mechanics spread your content without your compliance controls. Each platform is a different compliance challenge.

Three pillars of compliance. Built into every post.

IronPost Media doesn't bolt compliance onto your social media after the fact. Every piece of content is created within a regulatory framework from the start.

Pillar 01

FDA Fair Balance

Every benefit claim is matched with proportional risk disclosure. ISI linking on every promotional post. All claims verified against 510(k) summaries and approved labeling.

  • Benefit-risk parity in every post
  • ISI linking and safety information
  • Approved labeling as source of truth
  • Platform-specific formatting
🛑
Pillar 02

Off-Label Prevention

Content is locked to cleared indications before a single word is written. Hashtags screened, UGC protocols enforced, audience targeting restricted to approved populations.

  • Indication-locked content creation
  • Hashtag and keyword screening
  • UGC review protocol
  • Comment monitoring
🗃
Pillar 03

Audit-Ready Archiving

Every post archived with timestamped screenshots, approval chain documentation, version history, and adverse event response logs. Exportable for FDA inspection.

  • Timestamped content snapshots
  • Full approval chain documentation
  • Version history and change tracking
  • FDA-aligned retention policy

From brief to compliant post in four steps.

01

Device & Labeling Review

We start with your 510(k) summary, cleared indications, and IFU. This defines the compliance boundary — what we can and cannot say. No content is created before this step is complete.

02

Compliant Content Creation

Every post is written within the regulatory boundary. Fair balance is built in from the first draft — not bolted on during review. Platform-specific formatting ensures compliance works on LinkedIn, X, and Instagram.

03

Regulatory Review & Approval

Content moves through a documented approval chain: draft, regulatory review, medical/legal review, and final sign-off. Every stage is timestamped and archived. You see exactly what's going live and why it's compliant.

04

Publish & Archive

Posts go live with full compliance documentation. Timestamped screenshots, approval chains, and version history are archived automatically. If the FDA comes knocking, your social media archive is ready.

Every platform is a different compliance challenge.

FDA regulations don't change by platform, but the compliance risks do. We format regulatory requirements to fit each platform without compromising substance.

💼 LinkedIn
Risk: Reshares strip compliance context

Long-form format allows inline fair balance, but reshares and comments can spread your content without ISI links. We structure posts so compliance survives the share chain.

𝕏 X (Twitter)
Risk: Character limits compress disclosures

280 characters can't hold full safety information. We use link-in-bio strategies, thread structures, and compressed fair balance language that meets regulatory requirements within platform constraints.

📷 Instagram
Risk: Visual format obscures safety info

Image-first content buries required disclosures. We use caption-based fair balance, story highlights for ISI, and visual design that makes safety information visible — not hidden in fine print.

Built by someone who's sat through the FDA audits.

IronPost Media isn't a marketing agency that read the FDA guidance documents. It's built by a medtech operator who's led regulatory compliance, product launches, and commercial operations from inside the companies that make the devices.

John Duquette
Founder, IronPost Media — 20+ years in medical device leadership
🏥

VP Sales & Operations, Boston Medical Products

9+ years leading sales, marketing, and regulatory compliance for ENT and respiratory device lines.

📋

Regulatory operations from the inside

Prepped for FDA audits, managed QMS implementation, and led 510(k) submissions as the person responsible — not an outside consultant.

📈

Full commercial lifecycle experience

From 510(k) clearance to market launch to post-market surveillance. Roles at Hayek Medical Devices and Vapotherm spanning the full device lifecycle.

Medical device companies that can't afford a compliance mistake.

If your company posts on social media and you sell FDA-regulated devices, you need a compliance-first approach to content. Here's who we work with.

🏥

Growing device companies

You're scaling your social presence to support sales — but your regulatory team doesn't review social posts. One mistake from an eager marketing hire could trigger an FDA warning letter.

📋

Regulatory-conscious teams

Your regulatory team is stretched thin managing submissions and audits. They don't have bandwidth to review every LinkedIn post and Instagram story. IronPost Media handles the social compliance load.

🚀

Post-clearance launch phase

You just got 510(k) clearance and need to build market awareness fast. Speed matters — but so does compliance. We help you launch your social presence without regulatory risk.

Stop posting without a compliance net.

Every post your medtech company publishes without regulatory review is a risk. IronPost Media builds compliance into your social media from the ground up — Fair Balance, off-label prevention, and audit-ready archiving in every piece of content.

Request a Compliance Proposal →